# Effect of Naltrexone in Achieving and Maintaining Abstinence From Alcohol in Patients With Cirrhosis.

> **NCT04391764** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 100 (actual)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** Naltrexone
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04391764
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-06
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04391764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04391764, "Effect of Naltrexone in Achieving and Maintaining Abstinence From Alcohol in Patients With Cirrhosis.". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04391764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*